§ PHARMACEUTICALS
USD · Pharmaceuticals

TLRY

TILRAY BRANDS INC
USDSector · PharmaceuticalsBeta · 1.93
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
110 increased/new, 67 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B0.29EPS (TTM)-1.95
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Tidal Investments LLC2.6M0.0%+11%
UBS Group AG653K0.0%−16%
Morgan Stanley641K0.0%n/a
SUSQUEHANNA INTERNATIONAL GROUP, LLP542K0.0%+24%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.487K0.0%+43%
AQR Capital Management448K0.0%+285%
◇ AC INTELLIGENCE

Top institutional owners for TLRY as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER94.7% · 0 holders
OTHER3.5% · 165 holders
SYSTEMATIC / QUANT0.8% · 6 holders
DEALER / BANK0.4% · 23 holders
TACTICAL / MACRO0.3% · 1 holder
PASSIVE / INDEX0.2% · 6 holders
QUALITY / COMPOUNDER0.1% · 7 holders
INCOME / DEFENSIVE0.0% · 7 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TLRY in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention TLRY yet.